Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal estriol plus Lactobacillus acidophilus to prevent bacterial vaginosis in pessary users
TCTR20180329001Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Apr 2018
- Modality
- Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Trial of estriol and lactobacillus acidophilus in bacterial vaginosis (BV) and pelvic organ prolapse (POP), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Incidence of bacterial vaginosis. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
estriollactobacillus acidophilus
03
Conditions
bacterial vaginosis (BV)pelvic organ prolapse (POP)
Beyond the preview
Go deeper on TCTR20180329001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180329001.